tiprankstipranks
Trending News
More News >
Sirnaomics Ltd. (HK:2257)
:2257
Hong Kong Market
Advertisement

Sirnaomics Ltd. (2257) Price & Analysis

Compare
4 Followers

2257 Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.11%99.89%
Insiders
0.11%
Mutual Funds
― Other Institutional Investors
99.89% Public Companies and
Individual Investors

2257 FAQ

What was Sirnaomics Ltd.’s price range in the past 12 months?
Sirnaomics Ltd. lowest stock price was HK$2.35 and its highest was HK$6.95 in the past 12 months.
    What is Sirnaomics Ltd.’s market cap?
    Sirnaomics Ltd.’s market cap is HK$611.02M.
      When is Sirnaomics Ltd.’s upcoming earnings report date?
      Sirnaomics Ltd.’s upcoming earnings report date is Aug 28, 2025 which is in 43 days.
        How were Sirnaomics Ltd.’s earnings last quarter?
        Currently, no data Available
        Is Sirnaomics Ltd. overvalued?
        According to Wall Street analysts Sirnaomics Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Sirnaomics Ltd. pay dividends?
          Sirnaomics Ltd. does not currently pay dividends.
          What is Sirnaomics Ltd.’s EPS estimate?
          Sirnaomics Ltd.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Sirnaomics Ltd. have?
          Sirnaomics Ltd. has 105,166,176 shares outstanding.
            What happened to Sirnaomics Ltd.’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Sirnaomics Ltd.?
            Currently, no hedge funds are holding shares in HK:2257

            Sirnaomics Ltd. Stock Smart Score

            Company Description

            Sirnaomics Ltd.

            Sirnaomics Ltd. is a biopharmaceutical company focused on the discovery, development, and commercialization of RNA interference (RNAi) therapeutics. The company operates primarily in the biotechnology and pharmaceuticals sectors, with a focus on innovative treatments for oncology and fibrosis-related diseases. Through its proprietary technology platform, Sirnaomics develops drug candidates that harness the power of RNAi to silence disease-causing genes.
            Similar Stocks
            Company
            Price & Change
            Follow
            Transcenta Holding Limited
            SinoMab Bioscience Ltd.
            CStone Pharmaceuticals
            Clover Biopharmaceuticals Ltd.
            TOT BIOPHARM International Co. Ltd.
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis